| Returns | 1W : 1.1% , 1M : 14.1%,1Y : 36.1% |
| Peers & Returns | 1W | 1M | 1Y |
| ALBERT DAVID | 1.1% | 14.1% | 36.1% |
| SUN PHARMACEUTICAL INDUSTRIES | 15.6% | 16.8% | 51.9% |
| DR REDDYS LABORATORIES | -0.2% | -15.3% | 4.1% |
| DIVIS LABORATORIES | 2.4% | 10.8% | 92.4% |
| CIPLA | 4.2% | -5.3% | 34.4% |
| BIOCON | 2.1% | -4.4% | -3.3% |
| AUROBINDO PHARMA | 0.2% | -7.7% | 11.9% |
| LUPIN | 3.6% | -1.4% | 26.3% |
| TORRENT PHARMACEUTICALS | 0.6% | 5.2% | 26.2% |
| Ratio | Standalone |
|---|---|
|
P/E P/B P/S |
16.42
P/E Calculated based on EPS of 33.59
[ Mar2020 - Standalone Results ] 1.41
P/B Calculated based on Book Value of 390.38
[ Mar2020 - Standalone Results ] 1.27
P/S Calculated based on Revenues of 247.451 Cr
[ TTM - Standalone Results ] |
| Model | Discount(-)/ Premium(+) |
|---|---|
|
EV/EBIDTA EV/Sales Price/Sales |
157% 74% 95% |
| Pledged Shares |
0 % |
|---|---|
| As on : Jun2021 | |
If less than 25% | Good |
| If between 25% and 50% | Neutral |
| If greater than 50% | Bad |
| BSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| S&P BSE HEALTHCARE | 3.6% | 2% | 48.8% |
| S&P BSE SMALL CAP | 2.9% | 6.1% | 109.6% |
| S&P BSE ALLCAP | 2.7% | 3.4% | 54.8% |
| S&P BSE MIDSMALLCAP | 2.6% | 5.1% | 90.2% |
#15A, 4th Floor, City Vista, Tower A,
Suite No.984, Fountain Road,
Kharadi, Pune - 411014
Contact Us
support@smart-investing.in
Smart-Investing.in
Pricing
Video Course
Blog
Tools
Screener
Compare
Analyze Portfolio
© 2019 - 2021 Smart-Investing.in. All rights reserved. Built with ❤️ in India
Disclaimer
The information on this site is for educational purposes only and is not investment/trading advice/research and may be delayed.
We don't make any Buy/Sell recommendations and don't give any price targets.
This tool provides statistical summaries of financial data in easy to understand visual form for informational purpose only.
Please do your own research before making any investment decisions.
Equity investments are volatile and high risk in nature. Don't invest more than what you can afford to lose.
Financial Data Source: Accord Fintech |
Methodology |
Privacy Policy |
Terms & Conditions |
